Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [23425]

ASCO 2013: Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections

ASCO 2013: Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections

ASCO 2013: New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye

ASCO 2013: New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye

ASCO 2013: Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients with advanced melanoma

ASCO 2013: Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients with advanced melanoma

ASCO 2013: Adding GM-CSF to ipilimumab significantly improves survival compared to ipilimumab alone in patients with metastatic melanoma

ASCO 2013: Adding GM-CSF to ipilimumab significantly improves survival compared to ipilimumab alone in patients...

New method to test breast lesions could better detect cancer, save money by reducing repeat biopsies

New method to test breast lesions could better detect cancer, save money by reducing repeat biopsies

Cancer Research UK launches trial for potential new drug to block cancer cells' energy supply

Cancer Research UK launches trial for potential new drug to block cancer cells' energy supply

FDA approves the use of dabrafenib for treatment of metastatic melanoma

FDA approves the use of dabrafenib for treatment of metastatic melanoma

FDA approves use of trametinib for treatment of unresectable or metastatic melanoma

FDA approves use of trametinib for treatment of unresectable or metastatic melanoma

ASTRO claims radiation oncology research critically underfunded by NIH

ASTRO claims radiation oncology research critically underfunded by NIH

Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas

Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas

More from ecancer